Purdue Pharma and Sacklers agree to $7.4B opioid settlement.

[Chris]

Purdue Pharma and the Sackler family have agreed to a $7.4 billion settlement to address numerous lawsuits claiming their opioid medication, OxyContin, contributed significantly to the addiction crisis in the U.S., as announced by several state attorneys general on Thursday. This development presents a crucial moment in the ongoing battle against the opioid epidemic, highlighting the need for accountability in pharmaceutical practices.

It's interesting to ponder how this settlement might reshape the future of opioid-related litigation and public health policies. Could this set a precedent for how other pharmaceutical companies handle similar cases?

What are your thoughts on the implications of this settlement for the industry and affected communities? View the full details of the article here.

 

[somarco]

The Perdue Pharma/Sackler story is one of the most underreported stories of the last 25 years. The Sackler family is worth billions due to the marketing of Oxycontin as a safe, non-addictive painkiller.

The downfall of Perdue and the Sacklers in their own words . . .

The history of OxyContin, told through unsealed Purdue documents

In a newly unsealed 1996 email, Dr. Richard Sackler wrote that he wanted Purdue Pharma to be "feared as a tiger with claws, teeth and balls."

www.statnews.com